retatrutide side effects trial results New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide TRANSCEND-T2D-1 topline results are

This approach claims several pharmacological advantages, including better patient compliance due to ease of use and reduced risk of injection-site complications

Tian F, Huang S, Xu W, Chen L, Su J, Ni H, et al

Wear appropriate personal protective equipment (PPE), including gloves and lab coat, to avoid contamination

A conservative postpartum schedule looks like this: Weeks 1 through 8: 0.25 mg weekly Weeks 9 through 16: 0.5 mg weekly Weeks 17 through 24: 1.0 mg weekly Weeks 25 and beyond: 1.7 mg weekly (if needed, some women find 1.0 mg sufficient) Maximum dose: 2.4 mg weekly (Wegovy formulation) The key difference from standard protocols is patience

How long will it take to notice benefits

Perhaps most importantly, the compound's non-aggressive positioning is repeatedly praised